MHC class II gene regulation: Some historical considerations on a still ontogenetic and phylogenetic puzzle

Microbes and Infection

Volumn 1, Issue 11, 1999, Pages 871-877

  Accolla, Roberto S ^a,b   Tosi, Giovanna ^b   Sartoris, Silvia ^c   De Lerma Barbaro, Andrea ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b U of Cell and Molecular Genetics   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

GENE EXPRESSION REGULATION; GENETIC MANIPULATION; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR CLONING; ONTOGENY; PHYLOGENY; PRIORITY JOURNAL; PROMOTER REGION; REVIEW;

EID: 0032727213     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)00231-2     Document Type: Article

References (55)

1. Accolla R.S. Human B cell variants immunoselected against a single Ia antigen subset have lost expression of several Ia antigen subset. J. Exp. M. 157:1983;1053-1058.
2. Accolla R.S., Carra G., Guardiola J. Reactivation by a trans-acting factor of human major histocompatibility complex Ia gene expression in interspecies hybrids between an Ia-negative human B-cell variant and an Ia-positive mouse B-cell lymphoma. Proc. Natl. Acad. Sci. USA. 82:1985;5145-5149.
3. Accolla R.S., Scarpellino L., Carra G., Guardiola J. Trans-acting element (s) operating across species barriers positively regulate the expression of major histocompatibility complex class II genes. J. Exp. M. 162:1985;1117-1133.
4. Accolla R.S., Jotterand-Bellomo M., Scarpellino L., Maffei A., Carra G., Guardiola J. aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression. J. Exp. M. 164:1986;369-374.
5. Accolla R.S., Dellabona P., Scarpellino L., Carra G., Sartoris S. A family of trans-acting factors with distinct regulatory functions control expression of MHC class II genes. Immunol. Res. 9:1990;20-33.
6. Anichini A., Castelli C., Sozzi G., Fossati G., Parmiani G. Differential susceptibility to recombinant IFN-γ induced HLA-DQ antigen modulation among clones from a human metastatic melanoma. J. Immunol. 140:1988;183-191.
7. Armstrong T.D., Clements V.K., Martin B.K., Ting J.P.Y., Ostrand-Rosenberg S. Major histocompatibility complex-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity. Proc. Natl. Acad. Sci. USA. 94:1997;6886-6890.
8. Benichou B., Strominger J.L. Class II-antigen-negative patient and mutant B cell lines represent three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. USA. 88:1991;4285-4288.
9. Benoist C., Mathis D. Regulation of major histocompatibility complex class-II genes; X, Y, and other letters of the alphabet. Annu. Rev. Immunol. 8:1990;681-715.
10. Boyd R.L., Tukey C.L., Godfrey D.I., Izon D.J., Wilson T.J., Davidson N.J., Bean A.G.D., Ladyman H.M., Ritter M.A., Hugo P. The thymic microenvironment. Immunol. Today. 14:1993;445-459.
11. Calman A.J., Peterlin B.M. Evidence for a trans- acting factor that regulates the transcription of class II major histocompatibility complex genes: genetic and functional analysis. Proc. Natl. Acad. Sci. USA. 85:1988;8830-8834.
12. Chang C.H., Guerder S., Hong S.C., VanEwijk W., Flavell R.A. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity. 4:1996;167-178.
13. Clausen B.E., Waldburger J.M., Schwenk F., Barras E., Mach B., Rajewsky K., Forster I., Reith W. Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. Immunity. 8:1998;143-155.
14. DeLerma Barbaro A., Sartoris S., Tosi G., Nicolis M., Accolla R.S. Evidence for a specific post transcriptional mechanism controlling expression of HLA-DQ, but not DR and DP, molecules. J. Immunol. 153:1994;4530-4538.
15. DeLerma Barbaro A., Rigaud G., Sartoris S., Nicolis M., Cestari T., Accolla R.S. Divergent evolution in the mechanisms controlling MHC class II gene transcription in mouse and man. Eur. J. Immunol. 26:1996;259-262.
16. Dey A., Minucci S., Ozato K. Ligand dependent occupancy of retinoid acid receptor beta 2 promoter in vivo. Mol. Cell. Biol. 14:1994;8191-8201.
17. Durand B., Sperisen P., Emery P., Barras E., Zufferey M., Mach B., Reith W. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 16:1997;1045-1055.
18. Garrido F., Cabrera T., Concha A., Glew S., Ruiz-Cabello F., Stern P.L. Natural history of HLA expression during tumour development. Immunol. Today. 14:1993;491-499.
19. Gladstone S.D., Pious D.S. Stable variants affecting B cell alloantigens in human lymphoid cells. Nature. 271:1978;459-461.
20. Glimcher L.H., Kara C.J. Sequences and factors: a guide to MHC class-II transcription. Ann. Rev. Immunol. 10:1992;13-49.
21. Griscelli C., Lisowska-Grospierre B., Mach B. Combined immunodeficiency with defective expression in MHC class II genes. Immunodef. Rev. 1:1989;135-153.
22. Kara C.J., Glimcher L.H. In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science. 252:1991;709-712.
23. Kaufman J.F., Auffray C., Korman A.J., Schackelford D.A., Strominger J.L. The class II molecules of the human and murine MHC. Cell. 36:1984;1-13.
24. Kantor A.B., Herzenberg L.A. Origin of murine B cell lineages. Ann. Rev. Immunol. 11:1993;501-538.
25. Lam K.P., Stall A.M. Mayor histocompatibility complex class II expression distinguishes two distinct B cell developmental pathways during ontogeny. J. Exp. M. 180:1994;507-516.
26. Latron F., Jotterand-Bellomo M., Maffei A., Scarpellino L., Bernard M., Strominger J.L., Accolla R.S. Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells. Proc. Natl. Acad. Sci. USA. 85:1988;2229-2233.
27. Lennon A.M., Ottone C., Rigaud G., Deaven L.L., Longmire J., Fellous M., Bono R., Alcaïde-Loridan C. Isolation of a B-cell-specific promoter for the human class II transactivator. Immunogenetics. 45:1997;266-273.
28. Levine F., Pious D.S. Revertants from the HLA class II regulatory mutant 6: implications for the regulation of Ia gene expression. J. Immunol. 132:1984;959-962.
29. Lucey D.R., Nicholson-Weller A., Weller P.H. Mature human eosinophils have the capacity to express HLA-DR. Proc. Natl. Acad. Sci. USA. 86:1989;1348-1353.
30. Masternak K., Barras E., Zufferey M., Conrad B., Corthals G., Aebersold R., Sanchez J.C., Hochstrasser D.F., Mach B., Reith W. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genetics. 20:1998;273-277.
31. Muhlethaler-Mottet A., DiBerardino W., Otten L.A., Mach B., Activation O., FThe M., HC. class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1. Immunity. 8:1998;157-166.
32. Mueller P.R., Wold B. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science. 246:1989;780-786.
33. Ono S.J., Bazil V., Sugawara M., Strominger J.L. An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP. J. Exp. M. 173:1991;629-637.
34. Otten L.A., Steimle V., Bontron S., Mach B. Quantitative control of MHC class II expression by the transactivator CIITA. Eur. J. Immunol. 28:1998;473-478.
35. Piskurich J.F., Wang Y., Linhoff M.W., White L.C., Ting J.P.Y. Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-β-regulated expression of the class II transactivator gene. J. Immunol. 160:1998;233-240.
36. Rigaud G., Paiola F., Accolla R.S. In vivo modification of major histocompatibility complex class II DRA promoter occupancy mediated by the AIR-1 trans-activator. Eur. J. Immunol. 24:1994;2415-2420.
37. Rigaud G., De Lerma Barbaro A., Nicolis M., Cestari T., Ramarli D., Riviera A.P., Accolla R.S. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-γ J. Immunol. 156:1996;4254-4258.
38. Riley J.L., Westerheide S.D., Price J.A., Brown J.A., Boss J.M. Activation of class II MHC genes requires both the X regionand the class II transactivator (CIITA). Immunity. 2:1995;533-543.
39. Robinson J., Sieff C., Delia D., Edwards P.A.W., Greaves M. Expression of cell surface HLA-DR, HLA-ABC and glycophorin during erythroid differenciation. Nature. 289:1981;68-71.
40. Sartoris S., Accolla R.S. Transcriptional regulation of MHC class II genes. Int. J. Clin. Lab. Res. 25:1995;71-78.
41. Sartoris S., Tosi G., De LermaBarbaro A., Cestari T., Accolla R.S. Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells. Eur. J. Immunol. 26:1996;2456-2460.
42. Sartoris S., Valle M.T., De Lerma Barbaro A., Tosi G., Cestari T., D'Agostino A., Megiovanni A.M., Manca F., Accolla R.S. HLA class II expression in uninducible hepatocarcinoma cells after transfection of the AIR-1 gene product CIITA. Acquisition of antigen processing and presentation capacity. J. Immunol. 161:1998;814-820.
43. Scholl T., Mahanta S.K., Strominger J.L. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA. 94:1997;6330-6334.
44. Schuurman H.J., van de Wijngaert F.P., Huber J., Schuurman R.K., Zegers B.J., VanRood J.J., Kater L. The thymus in "bare lymphocyte" syndrome: significance of expression of major histocompatibility complex antigens on thymic epithelial cells in intrathymic T cell maturation. Hum. Immunol. 13:1985;69-82.
45. Scupoli M.T., Sartoris S., Tosi G., Ennas M.G., Nicolis M., Cestari T., Zamboni G., Martignoni G., Lemoine N.R., Scarpa A., Accolla R.S. Expression of MHC class I and class II antigens in pancreatic adenocarcinomas. Tissue Antigens. 48:1996;301-311.
46. Seidl C., Saraiya C., Osterweil Z., Fu Y.P., Lee J.S. Genetic complexity of regulatory mutants defective for HLA class II gene expression. J. Immunol. 148:1992;1576-1584.
47. Silacci P., Mottet A., Steimle V., Reith W., Mach B. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J. Exp. M. 180:1994;1329-1336.
48. Steimle V., Otten L.A., Zufferey M., Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or Bare Lymphocyte Syndrome). Cell. 75:1993;135-146.
49. Steimle V., Siegrist C.A., Mottet A., Lisowska-Grospierre B., Mach B. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science. 265:1994;106-109.
50. Steimle V., Durand B., Barras E., Zufferey M., Hadam M.R., Mach B., Reith W. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1995;1021-1032.
51. Steinmetz M. Structural and functional studies of mouse class II genes. Solheim B.G, Moller E, Ferrone S. HLA class II Antigens. 1986;109-127 Springer-Verlag, Berlin.
52. Ting J.P.Y., Baldwin A.S. Regulation of MHC gene expression. Curr. Opin. Immunol. 5:1993;8-16.
53. VonBoehmer H. Developmental biology of T cells in T cell receptor transgenic mice. Ann. Rev. Immunol. 8:1990;531-556.
54. Wright K.L., Ting J.P.Y. In vivo footprinting analysis of HLA-DR promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon-gamma. Proc. Natl. Acad. Sci. USA. 89:1992;7601-7605.
55. Wright K.L., Chin K.C., Linhoff M., Skinner C., Brown J.A., Boss J.M., Stark G.R., Ting J.P.Y. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc. Natl. Acad. Sci. USA. 95:1998;6267-6272.